Breaking News

PSI Expands International Presence

July 25, 2013

Opens site in South Africa

PSI CRO is expanding into South Africa, establishing an office in Pretoria. PSI will expand its access to all African countries from this location. PSI’s current experience in South Africa covers oncology, CNS, urology, diabetes and other therapeutic areas.
South Africa is a multi-cultural nation with a population of approximately 50 million people, and has a long history of conducting clinical trials. The region has a strong infrastructure to support all activities including regulatory oversight and experienced researchers. Additionally, data generated from South African trials is accepted internationally.

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research